Pro Football Hall of Famer to Speak at Cannabis Business Summit

[dropcap class=”kp-dropcap”]P[/dropcap]ro Football Hall of Fame running back and former Denver Broncos star Terrell Davis will serve as the keynote speaker at an upcoming MCBA Opportunity Summit that will be held in Denver March 22-24. Davis, now and entrepreneur and businessman, is expected to speak on his life in and out of football, overcoming adversity and dealing with racism.

“I am sincerely looking forward to the opportunity to address fellow minority business owners and supports of minority entrepreneurs,” Davis said in a press release announcing his speech.

The Minority Cannabis Business Association (MCBA) is a non-profit organization founded in 2015 with the aim of working with minority cannabis entrepreneurs, workers and patients and consumers. The summit, the organization’s first, will focus on providing resources, information and connections to businesses and entrepreneurs from communities impacted by the war on drugs.  The summit will also feature the launch of MCBA’s expungement and record-sealing clinics in Colorado, which aim to remove or seal nonviolent drug offenses from records of people looking for fairness in employment and housing.

The three-day program will provide an educational and professional opportunity for minority entrepreneurs to learn from and meet some of the industry’s experts. Other speakers include Wanda James, Zairilla Bacon, Dr. Rachel Knox and Reuben Droughns.

After NFL Commissioner Roger Goodell said he believes cannabis has an “addictive nature,” the league reached out to the NFL Players Association to jointly research the medicinal benefits of consuming cannabis for pain management. Other former Broncos Jake Plummer and Ebenezer Ekuban are other ex-players that have been vocal about the benefits of cannabis.

While Davis hasn’t publicly stated his stance on cannabis, the former running back was known to suffer from and play through migraine headaches throughout his career, and cannabis-based medicine has been shown to reduce migraine pain better than traditional migraine medicines.